Are you interested in the intersection between healthcare and technology? Do you want to know how mobile technologies are changing the healthcare industry?
Join Brian Coe (Chief Executive Officer and co-founder of SlipChip Corporation), Steve Gould (Founder and Principal of The Gould Consulting Group), Bob Zieserl (Managing Director of KB Partners Venture Fund) and David Beiser (Assistant Professor in the Section of Emergency Medicine at the University of Chicago) for an hour-long discussion on the past, present and future of mobile in healthcare. It promises to be an insightful and inspiring conversation.
When: November 7, noon
Where: Donnelly Biological Sciences Learning Center (BSLC) Auditorium 115 924 E 57 ST, Chicago, IL 60637
Refreshments will be served.
Brian Coe is Chief Executive Officer and co-founder of SlipChip Corporation, which is developing a micro-fluidic platform for conducting quantitative molecular and measurement assays in research and clinical laboratories. He currently serves as Chairman of Euclid Diagnostics, an epigenetics company he co-founded and is Adjunct Professor Entrepreneurship Chicago Booth and the Entrepreneur-in-Residence for healthcare at the Michael P. Polsky Center for Entrepreneurship at Chicago Booth.
Steve Gould has extensive and broad-based experience in both clinical and scientific research in an academic environment, and executive management throughout the entire life cycle of an entrepreneurial biotechnology company. He is the Founder and Principal of The Gould Consulting Group LLC, which provides advisory services to companies and universities seeking to develop and capitalize on biotechnology and life science innovations, and to venture investors evaluating promising and potentially transforming companies working in areas of disruptive science. Steve was previously a scientific founder and Chairman and CEO of Northfield Laboratories Inc., a publicly traded biotechnology company that was focused on developing a hemoglobin-based oxygen carrier as a blood substitute. Prior to Northfield he was Chief of Surgery at Michael Reese Hospital and Medical Center and Professor of Surgery at the University of Chicago and then the University of Illinois at Chicago.
Bob Zieserl is a serial entrepreneur, venture capitalist, and angel investor with primary focus on healthcare informatics, diagnostics, devices and other technologies addressing major needs in medical care and wellness. He is Managing Director of KB Partners Venture Fund, on the Verax Biomedical Board, and advisor and former Chairman of VGBio. He advises and mentors start-ups and is works with HealthBox, iBio Propel, Chicago Innovation Mentors (CIM), Northwestern INVO and University of Chicago UCTech.
David Beiser is an Assistant Professor in the Section of Emergency Medicine at the University of Chicago. Prior to medical school, he identified as an engineer, working in the medical device industry and later pursuing graduate training in biomedical engineering at Northwestern University. For the past several years, he has been an NIH-funded researcher in cardiovascular science.